Form 8-K - Current report:
SEC Accession No. 0001558370-22-014215
Filing Date
2022-09-07
Accepted
2022-09-07 06:31:42
Documents
13
Period of Report
2022-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220831x8k.htm   iXBRL 8-K 48023
2 EX-10.1 tmb-20220831xex10d1.htm EX-10.1 1259156
  Complete submission text file 0001558370-22-014215.txt   1620174

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20220831.xsd EX-101.SCH 3029
4 EX-101.LAB tmb-20220831_lab.xml EX-101.LAB 15361
5 EX-101.PRE tmb-20220831_pre.xml EX-101.PRE 10999
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220831x8k_htm.xml XML 4648
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 221229872
SIC: 2836 Biological Products, (No Diagnostic Substances)